1: Monti JM. Serotonin control of sleep-wake behavior. Sleep Med Rev. 2011 Aug;15(4):269-81. doi: 10.1016/j.smrv.2010.11.003. Epub 2011 Apr 2. PMID: 21459634.
2: McDougall SA, Taylor JA, Roe MJ, Greenwood CJ. Effects of repeated treatment with the 5-HT1A and 5-HT1B agonists (R)-( +)-8-hydroxy- DPAT and CP-94253 on the locomotor activity and axillary temperatures of preweanling rats: evidence of tolerance and behavioral sensitization. Psychopharmacology (Berl). 2022 Feb;239(2):413-427. doi: 10.1007/s00213-021-06012-5. Epub 2021 Nov 24. PMID: 34816290.
3: McDougall SA, Roe MJ, Robinson JAM, Cotter LL, Gonzalez DJ, Gleason DC, Crawford CA. Effects of the serotonin 5-HT1B receptor agonist CP 94253 on the locomotor activity and body temperature of preweanling and adult male and female rats. Eur J Pharmacol. 2022 Jul 5;926:175019. doi: 10.1016/j.ejphar.2022.175019. Epub 2022 May 10. PMID: 35561752.
4: Wesołowska A, Nikiforuk A, Chojnacka-Wójcik E. Anticonvulsant effect of the selective 5-HT1B receptor agonist CP 94253 in mice. Eur J Pharmacol. 2006 Jul 10;541(1-2):57-63. doi: 10.1016/j.ejphar.2006.04.049. Epub 2006 May 7. PMID: 16765343.
5: Tatarczyńska E, Antkiewicz-Michaluk L, Kłodzińska A, Stachowicz K, Chojnacka- Wójcik E. Antidepressant-like effect of the selective 5-HT1B receptor agonist CP 94253: a possible mechanism of action. Eur J Pharmacol. 2005 May 23;516(1):46-50. doi: 10.1016/j.ejphar.2005.04.025. PMID: 15913599.
6: Monti JM, Jantos H, Lagos P. Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat. Behav Brain Res. 2010 Jan 5;206(1):8-16. doi: 10.1016/j.bbr.2009.08.037. Epub 2009 Sep 6. PMID: 19737581.
7: Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E. Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression. Behav Pharmacol. 2004 Dec;15(8):523-34. doi: 10.1097/00008877-200412000-00001. PMID: 15577451.
8: Skelin I, Kovačević T, Sato H, Diksic M. The opposite effect of a 5-HT1B receptor agonist on 5-HT synthesis, as well as its resistant counterpart, in an animal model of depression. Brain Res Bull. 2012 Aug 1;88(5):477-86. doi: 10.1016/j.brainresbull.2012.04.009. Epub 2012 Apr 20. PMID: 22542420; PMCID: PMC3653842.
9: Hayes DJ, Graham DA, Greenshaw AJ. Effects of systemic 5-HT(1B) receptor compounds on ventral tegmental area intracranial self-stimulation thresholds in rats. Eur J Pharmacol. 2009 Feb 14;604(1-3):74-8. doi: 10.1016/j.ejphar.2008.12.023. Epub 2008 Dec 24. PMID: 19135047.
10: Przegaliński E, Gołda A, Frankowska M, Zaniewska M, Filip M. Effects of serotonin 5-HT1B receptor ligands on the cocaine- and food-maintained self- administration in rats. Eur J Pharmacol. 2007 Mar 22;559(2-3):165-72. doi: 10.1016/j.ejphar.2006.12.012. Epub 2007 Jan 16. PMID: 17291490.
11: Lee MD, Simansky KJ. CP-94, 253: a selective serotonin1B (5-HT1B) agonist that promotes satiety. Psychopharmacology (Berl). 1997 Jun;131(3):264-70. doi: 10.1007/s002130050292. PMID: 9203237.
12: Miszkiel J, Przegaliński E. Effects of serotonin (5-HT)1B receptor ligands on amphetamine-seeking behavior in rats. Pharmacol Rep. 2013;65(4):813-22. doi: 10.1016/s1734-1140(13)71062-4. PMID: 24145075.
13: Miszkiel J, Adamczyk P, Filip M, Przegaliński E. The effect of serotonin 5HT1B receptor ligands on amphetamine self-administration in rats. Eur J Pharmacol. 2012 Feb 29;677(1-3):111-5. doi: 10.1016/j.ejphar.2011.12.033. Epub 2011 Dec 29. PMID: 22227331.
14: Stamford JA, Davidson C, McLaughlin DP, Hopwood SE. Control of dorsal raphé 5-HT function by multiple 5-HT(1) autoreceptors: parallel purposes or pointless plurality? Trends Neurosci. 2000 Oct;23(10):459-65. doi: 10.1016/s0166-2236(00)01631-3. PMID: 11006462.
15: McDevitt RA, Hiroi R, Mackenzie SM, Robin NC, Cohn A, Kim JJ, Neumaier JF. Serotonin 1B autoreceptors originating in the caudal dorsal raphe nucleus reduce expression of fear and depression-like behavior. Biol Psychiatry. 2011 Apr 15;69(8):780-7. doi: 10.1016/j.biopsych.2010.12.029. Epub 2011 Feb 26. PMID: 21353664; PMCID: PMC3080128.
16: Chojnacka-Wójcik E, Kłodzińska A, Tatarczyńska E. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action. J Pharm Pharmacol. 2005 Feb;57(2):253-7. doi: 10.1211/0022357055399. PMID: 15720791.
17: Przegaliński E, Gołda A, Filip M. Effects of serotonin (5-HT)(1B) receptor ligands on cocaine-seeking behavior in rats. Pharmacol Rep. 2008 Nov- Dec;60(6):798-810. PMID: 19211971.
18: Miczek KA, Fish EW, De Bold JF, De Almeida RM. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Psychopharmacology (Berl). 2002 Oct;163(3-4):434-58. doi: 10.1007/s00213-002-1139-6. Epub 2002 Aug 6. PMID: 12373445.
19: Li Y, Pehrson AL, Oosting RS, Gulinello M, Olivier B, Sanchez C. A study of time- and sex-dependent effects of vortioxetine on rat sexual behavior: Possible roles of direct receptor modulation. Neuropharmacology. 2017 Jul 15;121:89-99. doi: 10.1016/j.neuropharm.2017.04.017. Epub 2017 Apr 13. PMID: 28414050.
20: Liu Y, Gibson AW, Levinstein MR, Lesiak AJ, Ong SE, Neumaier JF. 5-HT1B Receptor-Mediated Activation of ERK1/2 Requires Both Gαi/o and β-Arrestin Proteins. ACS Chem Neurosci. 2019 Jul 17;10(7):3143-3153. doi: 10.1021/acschemneuro.8b00596. Epub 2019 Apr 29. PMID: 30946562; PMCID: PMC7217031.